Integral Ad Science Holding Corp. (NASDAQ:IAS - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the twelve brokerages that are presently covering the company, MarketBeat Ratings reports. Six analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $13.55.
Several equities research analysts have recently weighed in on IAS shares. Raymond James Financial increased their price objective on shares of Integral Ad Science from $11.00 to $13.00 and gave the stock an "outperform" rating in a research report on Tuesday, May 13th. Barclays increased their price objective on shares of Integral Ad Science from $7.00 to $9.00 and gave the stock an "equal weight" rating in a research report on Tuesday, May 13th. Wall Street Zen upgraded shares of Integral Ad Science from a "hold" rating to a "buy" rating in a research report on Saturday, June 14th. Robert W. Baird reiterated a "neutral" rating and set a $9.00 price objective (down from $16.00) on shares of Integral Ad Science in a research report on Friday, March 28th. Finally, Stifel Nicolaus dropped their target price on shares of Integral Ad Science from $15.00 to $13.00 and set a "buy" rating on the stock in a research report on Wednesday, April 23rd.
Get Our Latest Stock Report on Integral Ad Science
Integral Ad Science Trading Down 0.6%
NASDAQ:IAS traded down $0.05 during mid-day trading on Thursday, hitting $8.04. 977,788 shares of the company's stock were exchanged, compared to its average volume of 967,389. The company has a 50 day simple moving average of $7.80 and a 200-day simple moving average of $8.93. The company has a current ratio of 4.01, a quick ratio of 4.01 and a debt-to-equity ratio of 0.01. Integral Ad Science has a fifty-two week low of $6.26 and a fifty-two week high of $13.62. The firm has a market capitalization of $1.33 billion, a P/E ratio of 27.72, a PEG ratio of 1.37 and a beta of 1.59.
Integral Ad Science (NASDAQ:IAS - Get Free Report) last posted its quarterly earnings data on Monday, May 12th. The company reported $0.05 EPS for the quarter, beating analysts' consensus estimates of $0.03 by $0.02. Integral Ad Science had a net margin of 8.56% and a return on equity of 4.74%. The company had revenue of $134.07 million for the quarter, compared to analyst estimates of $129.20 million. As a group, research analysts expect that Integral Ad Science will post 0.26 earnings per share for the current year.
Insiders Place Their Bets
In other Integral Ad Science news, CEO Lisa Utzschneider sold 8,547 shares of the company's stock in a transaction on Monday, April 7th. The shares were sold at an average price of $6.85, for a total transaction of $58,546.95. Following the transaction, the chief executive officer now owns 341,271 shares in the company, valued at approximately $2,337,706.35. This represents a 2.44% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Over the last 90 days, insiders have sold 86,222 shares of company stock worth $636,252. Insiders own 2.00% of the company's stock.
Institutional Trading of Integral Ad Science
Several institutional investors have recently made changes to their positions in the company. Vanguard Group Inc. grew its stake in shares of Integral Ad Science by 0.5% in the 1st quarter. Vanguard Group Inc. now owns 9,090,229 shares of the company's stock worth $73,267,000 after acquiring an additional 41,683 shares in the last quarter. Sunriver Management LLC grew its stake in shares of Integral Ad Science by 12.0% in the 1st quarter. Sunriver Management LLC now owns 8,166,774 shares of the company's stock worth $65,824,000 after acquiring an additional 875,740 shares in the last quarter. Alyeska Investment Group L.P. bought a new stake in shares of Integral Ad Science in the 4th quarter worth $41,543,000. Dimensional Fund Advisors LP grew its position in Integral Ad Science by 18.1% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,789,996 shares of the company's stock valued at $39,567,000 after buying an additional 580,323 shares during the period. Finally, Corvex Management LP bought a new position in Integral Ad Science during the first quarter valued at about $21,101,000. Institutional investors own 95.78% of the company's stock.
Integral Ad Science Company Profile
(
Get Free ReportIntegral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.
Further Reading

Before you consider Integral Ad Science, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integral Ad Science wasn't on the list.
While Integral Ad Science currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.